Is Diabetes a Risk Factor for Long COVID? Possibly.

Loading

— Mixed results in seven-study scoping review

The jury is still out as to whether diabetes is a risk factor for post-acute sequelae of COVID-19 (PASC), a researcher reported.

In a scoping review of seven studies, three (43%) concluded that diabetes was indeed a “potent” risk factor for developing long COVID following infection, according to Jessica L. Harding, PhD, of Emory University School of Medicine in Atlanta.
Read more in MedPage Today.

Loading

HBCU Medical Schools to Tackle Organ Transplant Disparities

Loading

A coalition including the four medical schools at the nation’s historically Black colleges and universities has announced a new initiative aimed at increasing the number of Black Americans registered as organ donors and combating disparities among transplant recipients.

A new initiative aimed at increasing the number of Black Americans registered as organ donors and combating disparities among transplant recipients was announced Thursday by a coalition that includes the four medical schools at the nation’s historically Black colleges and universities. Read more in U.S. News & World Report.

Loading

Action needed to combat elevated risk for depression, suicide in diabetes

Loading

NEW ORLEANS — Risks for depression and suicidal ideation are higher among people with vs. without diabetes, and cases of suicide are likely underreported, according to a presenter at the American Diabetes Association Scientific Sessions.

Katharine Barnard-Kelly, PhD, chief science officer at Spotlight Consultations in Portsmouth, U.K., professor at the Southern Health NHS Foundation Trust and chair of the governing committee of the FDA Reducing Suicide Rates Among Individuals with Diabetes (RESCUE) Collaborative Community, said depression, suicidal ideation and self-harm are more common among people with diabetes than many people realize, affecting both men and women as well as all age groups. Read more in Healio here.

Loading

Interdisciplinary care led to transplant listings for underrepresented groups with ESKD

Loading

Interdisciplinary care was associated with higher odds of being listed for kidney transplant among patients with incident end-stage kidney disease in underrepresented groups, according to this study.

Further, researchers found interdisciplinary care provides better ESKD preparedness than the usual nephrology care in this population. Read more in Healio.

Loading

Up to 1 in 4 adult survivors experience at least one long COVID symptom

Loading

COVID-19 survivors face a significantly higher risk than control patients for developing conditions affecting major system of the body, according to a study of nearly 2 million patients.

For example, up to one-quarter of people who have had COVID-19 experience at least one symptom of long COVID, the most common of which are acute pulmonary embolism and respiratory symptoms, researchers reported Tuesday in MMWR. Read more in Healio.

Loading

Living organ donations save lives. This is how you become a donor

Loading

(CNN) Samira Jafari is at home now resting from a surgery that saved a life — not her own, but her colleague’s.

The deputy managing editor of CNN’s investigations unit answered the request for employees to be tested to find a donor for Senior UN Correspondent Richard Roth, who needed a kidney transplant, and found that her blood and tissue was a match.
Read the full story from CNN Health.

Loading

CKD, Recent Transplant May Increase Cancer Risk, Study Finds

Loading

A population-based cohort study found that patients with chronic kidney disease (CKD) or who underwent a recent kidney transplant had a higher risk of cancer compared with people with normal kidney function.

A study published in American Journal of Kidney Diseases found that the risk of cancer was higher in patients with mild to moderate chronic kidney disease (CKD) and in kidney transplant recipients vs patients with normal kidney function. Patients with kidney disease also had a higher risk of cancer-related mortality.
Read more in the American Journal of Managed Care (AJMC).

Loading

Novel Type 1 diabetes treatment involves pancreatic islet transplant without the need for immunosuppression

Loading

In a new study, a team of researchers from the University of Missouri, Georgia Tech and Harvard University has demonstrated the successful use of a novel Type 1 diabetes treatment in a large animal model. Their approach involves transplanting insulin-producing pancreas cells -; called pancreatic islets -; from a donor to a recipient, without the need of long-term immunosuppressive drugs.

In people living with Type 1 diabetes, their immune system can malfunction, causing it to attack itself, said Haval Shirwan, a professor of child health and molecular microbiology and immunology in the MU School of Medicine, and one of the study’s lead authors.
Read more in News Medical Life Science.

Loading

Older living kidney donor age may be negative predictor of recipient, graft survival

Loading

Compared with living donors aged 50 to 70 years, donor age older than 70 years may be a negative predictor of kidney transplant and graft survival, according to a presentation at the American Transplant Congress.

“I set out to see if the data and outcomes of a national cohort met my anecdotal findings that living kidney donor transplants from donors [older than] 70 years don’t perform as well compared to their younger donor counterparts regardless of measured donor GFR and noted that this had not been studied in a contemporary cohort in the past 10 years,” Adam Bregman, MD, MBA, an assistant professor of medicine in the division of nephrology and hypertension at the University of Minnesota, told Healio. Read more in Healio.

Loading